TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma.

Daniel J Herr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.